Cytomegalovirus infection after renal transplantation: Selective prophylaxis and treatment

Transplantation Proceedings

Volumn 35, Issue 5, 2003, Pages 1756-1757

  Pascual, Julio ^a   Alarcon M C ^a   Marcen R ^a   Burgos, F J ^a   Tato, A ^a   Tenorio, M T ^a   Liano F ^a   Ortuno J ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOSPORIN A; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; TACROLIMUS;

CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

EID: 0041330661     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00716-4     Document Type: Conference Paper

References (4)

1. Brennan D.C. J Am Soc Nephrol. 12:2001;848.
2. Gourishankar S., Wong W., Dorval M. Transplant Proc. 33:2001;1870.
3. Ahsan N., Holman M.J., Sonderbye L., et al. Transplant Proc. 30:1998;1383.
4. European Best Practice Guidelines for Renal Transplantation (Part 1). Nephrol Dial Transplant. 15:(suppl 7):2000;71.